Form 4: Harrow Inc. Director Lauren P. Silvernail Reports Acquisition of Restricted Stock Units

Lauren P. Silvernail, a director at Harrow Inc., reported the acquisition of 8,347 Restricted Stock Units (RSUs) on June 14, 2024, as a compensatory award.

Summary

• On June 14, 2024, Lauren P. Silvernail, a director of Harrow, Inc. acquired 8,347 Restricted Stock Units (RSUs).
• The RSUs were granted as a compensatory award for services rendered or to be rendered.
• The RSUs vest quarterly in equal installments over a one-year period following the grant date.
• The underlying shares will not be delivered, transferred, or sold until the termination of service.

Sentiment

Score: 7

Explanation: The document reflects a routine compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.

Positives

• The acquisition of RSUs indicates continued alignment of the director's interests with the company's performance.

Future Outlook

The RSUs vest quarterly over a one-year period, indicating a continued service commitment from the director.

Industry Context

This is a standard practice for compensating directors and aligning their interests with the long-term performance of the company. RSU grants are common in publicly traded companies.

Comparison to Industry Standards

• RSU grants to directors are a common practice across the pharmaceutical and healthcare industries.
• Companies like Teva Pharmaceutical Industries Ltd. and Mylan N.V. (now Viatris Inc.) also utilize RSU grants as part of their director compensation packages.
• The vesting schedule of quarterly installments over one year is also fairly standard.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of the shareholders, encouraging decisions that benefit the company's long-term value.

Key Dates